Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

SALL4 is a key regulator of survival and apoptosis in human leukemic cells.

Yang J, Chai L, Gao C, Fowles TC, Alipio Z, Dang H, Xu D, Fink LM, Ward DC, Ma Y.

Blood. 2008 Aug 1;112(3):805-13. doi: 10.1182/blood-2007-11-126326. Epub 2008 May 16. Erratum in: Blood. 2009 Oct 1; 114(14):3131.

2.

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.

Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10494-9. Epub 2007 Jun 8.

3.

Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.

Lu J, Jeong HW, Kong N, Yang Y, Carroll J, Luo HR, Silberstein LE, Yupoma, Chai L.

PLoS One. 2009;4(5):e5577. doi: 10.1371/journal.pone.0005577. Epub 2009 May 18. Erratum in: PLoS One. 2009;4(7). doi: 10.1371/annotation/e0bd3a57-1ce4-4eaf-83de-034d39cac787. Jeong, Hawon [corrected to Jeong, Ha-Won].

4.

The role of stem cell factor SALL4 in leukemogenesis.

Gao C, Kong NR, Chai L.

Crit Rev Oncog. 2011;16(1-2):117-27. Review.

5.

A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.

Li A, Yang Y, Gao C, Lu J, Jeong HW, Liu BH, Tang P, Yao X, Neuberg D, Huang G, Tenen DG, Chai L.

J Clin Invest. 2013 Oct;123(10):4195-207. doi: 10.1172/JCI62891. Epub 2013 Sep 24.

6.

Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.

Gao C, Dimitrov T, Yong KJ, Tatetsu H, Jeong HW, Luo HR, Bradner JE, Tenen DG, Chai L.

Blood. 2013 Feb 21;121(8):1413-21. doi: 10.1182/blood-2012-04-424275. Epub 2013 Jan 3.

7.

SALL4 is a key transcription regulator in normal human hematopoiesis.

Gao C, Kong NR, Li A, Tatetu H, Ueno S, Yang Y, He J, Yang J, Ma Y, Kao GS, Tenen DG, Chai L.

Transfusion. 2013 May;53(5):1037-49. doi: 10.1111/j.1537-2995.2012.03888.x. Epub 2012 Aug 31.

8.

Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.

Cui W, Kong NR, Ma Y, Amin HM, Lai R, Chai L.

Mod Pathol. 2006 Dec;19(12):1585-92. Epub 2006 Sep 22.

9.

Leukemic survival factor SALL4 contributes to defective DNA damage repair.

Wang F, Gao C, Lu J, Tatetsu H, Williams DA, Müller LU, Cui W, Chai L.

Oncogene. 2016 Nov 24;35(47):6087-6095. doi: 10.1038/onc.2016.146. Epub 2016 May 2.

10.

Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.

Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19756-61. doi: 10.1073/pnas.0809321105. Epub 2008 Dec 5.

11.

Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target.

Ueno S, Lu J, He J, Li A, Zhang X, Ritz J, Silberstein LE, Chai L.

Exp Hematol. 2014 Apr;42(4):307-316.e8. doi: 10.1016/j.exphem.2014.01.005. Epub 2014 Jan 23.

12.

Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

de Figueiredo-Pontes LL, Assis PA, Santana-Lemos BA, Jácomo RH, Lima AS, Garcia AB, Thomé CH, Araújo AG, Panepucci RA, Zago MA, Nagler A, Falcão RP, Rego EM.

PLoS One. 2011;6(10):e26713. doi: 10.1371/journal.pone.0026713. Epub 2011 Oct 28.

13.

[Effects of simvastatin plus all-trans retinoic acid on WT1/hDMP1 gene expression profiles of human promyelocytic leukemia cell line NB4].

Jiang TX, Gu WY, Qiu GQ, Chen ZX, Wang ZL, Wu HQ, Hua XY, He B, Wu W, Xie XB, Cao XS.

Zhonghua Yi Xue Za Zhi. 2011 Jul 12;91(26):1856-60. Chinese.

PMID:
22093791
14.

Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.

Abecassis I, Maes J, Carrier JL, Hillion J, Goodhardt M, Medjber K, Wany L, Lanotte M, Karniguian A.

Leukemia. 2008 Mar;22(3):511-20. Epub 2007 Dec 20.

PMID:
18094716
15.

[Influence of I2PP2A gene silencing by RNA interference on proliferation and apoptosis of human acute promyelocytic leukemia cell line NB4-R1].

Liu Y, He P, Liu F, Cheng X, Zhang M.

Zhonghua Xue Ye Xue Za Zhi. 2014 Aug;35(8):732-6. doi: 10.3760/cma.j.issn.0253-2727.2014.08.014. Chinese.

PMID:
25152123
16.

Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells.

Yang L, Zhao H, Li SW, Ahrens K, Collins C, Eckenrode S, Ruan QG, McIndoe RA, She JX.

J Mol Diagn. 2003 Nov;5(4):212-21.

17.

SALL4 is a new target in endometrial cancer.

Li A, Jiao Y, Yong KJ, Wang F, Gao C, Yan B, Srivastava S, Lim GS, Tang P, Yang H, Tenen DG, Chai L.

Oncogene. 2015 Jan 2;34(1):63-72. doi: 10.1038/onc.2013.529. Epub 2013 Dec 16.

19.

Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.

He J, Zhang W, Zhou Q, Zhao T, Song Y, Chai L, Li Y.

Int J Biochem Cell Biol. 2013 Sep;45(9):1962-73. doi: 10.1016/j.biocel.2013.06.008. Epub 2013 Jun 28.

PMID:
23811124
20.

A New Indole Derivative Decreased SALL4 Gene Expression in Acute Promyelocytic Leukemia Cell Line (NB4)

Sheikhrezaei Z, Heydari P, Farsinezhad A, Fatemi A, Khanamani Falahati-Pour S, Darakhshan S, Noroozi Karimabad M, Darekordi A, Khorramdelazad H, Hassanshahi G.

Iran Biomed J. 2017 Aug 12. [Epub ahead of print]

Supplemental Content

Support Center